SHIONOGI & CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,211 JPY | +0.88% |
|
+1.36% | +6.08% |
| Apr. 25 | Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Apr. 19 | Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares | MT |
ETFs positioned on Shionogi & Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 15 M€ | +6.73% | ||
| 2.51% | 5 M€ | +6.34% | - | |
| 1.07% | 60 M€ | +13.65% | ||
| 1.05% | 11 M€ | +10.37% | - | |
| 1.04% | 251 M€ | +13.17% | ||
| 0.92% | 67,864 M€ | +13.85% | ||
| 0.86% | 15 M€ | +13.36% | ||
| 0.85% | 31,732 M€ | +13.93% | - | |
| 0.85% | 1,198 M€ | +13.21% | - | |
| 0.84% | 51 M€ | -.--% | - | |
| 0.84% | 174 M€ | -.--% | - | |
| 0.72% | 16,729 M€ | +12.95% | - | |
| 0.61% | 2 M€ | -.--% | - | |
| 0.61% | 2 M€ | +9.19% | - | |
| 0.59% | 73 M€ | +11.61% | ||
| 0.54% | 81 M€ | +14.29% | ||
| 0.40% | 14 M€ | +15.63% | ||
| 0.38% | 18 M€ | +16.15% | - | |
| 0.36% | 10,207 M€ | +13.83% | ||
| 0.36% | 5,115 M€ | +13.47% | ||
| 0.34% | 26 M€ | +18.33% | ||
| 0.26% | 66,066 M€ | +14.28% | - | |
| 0.26% | 144,586 M€ | +14.20% | ||
| 0.26% | 20,721 M€ | +13.10% | - | |
| 0.10% | 4 M€ | -.--% | - | |
| 0.08% | 7 M€ | +1.38% | - | |
| 0.07% | 10 M€ | -3.35% | - | |
| 0.06% | 7 M€ | +0.11% | - | |
| 0.06% | 277 M€ | -.--% | - | |
| 0.05% | 194 M€ | +6.04% | - |
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,148
JPY
Average target price
7,721
JPY
Spread / Average Target
+8.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.08% | 13.42B | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- 4507 Stock
- Funds and ETFs Shionogi & Co., Ltd.
